Why do young people have strokes?
28 January, 2015Researchers from The Centenary Institute, Sydney, have announced a breakthrough in understanding the cause of stroke in young people. The leader of the research, Dr Xiangjian Zheng, said the stroke in question affects around five in every 1000 people, many of whom are diagnosed in their 30s and 40s.
Regulatory registration of Qiagen lung cancer companion diagnostic
14 January, 2015Qiagen has announced the CE-IVD marking of its liquid biopsy-based companion diagnostic that analyses circulating nucleic acids obtained from blood samples to assess a genomic mutation in patients with non-small cell lung cancer (NSCLC).
Identification of a pre-cancerous state in the blood
10 December, 2014US researchers have uncovered a 'pre-malignant' state in the blood that significantly increases the likelihood that an individual will develop blood cancers such as leukaemia, lymphoma or myelodysplastic syndrome.
Low-cost technique to detect rotavirus
08 October, 2014Researchers at the Universidad Politécnica de Madrid (UPM) have found a new, low-cost way to enhance detection capacity of small concentrations of rotavirus - a sphere-shaped virus up to 75 nm in diameter that has the appearance of a wheel, seen from an electron microscope.
The molecular details of coeliac disease
01 May, 2014Australian, US and Dutch researchers have determined the molecular details of the interaction between the immune system and gluten that triggers coeliac disease.
Starpharma tech applied to AstraZeneca cancer drug
08 April, 2014Melbourne-based biotech company Starpharma has signed an expanded agreement with biopharma company AstraZeneca in the field of cancer medicine. The new agreement will see the application of Starpharma's dendrimer technology to a cancer drug from AstraZeneca's pipeline.
Diagnostic device meets malaria field evaluation objective
25 March, 2014Fio Corporation's Deki Reader - a mobile in vitro diagnostic device - has demonstrated consistent interpretation of rapid diagnostic tests (RDTs) for multiple malaria strains in a field evaluation.
Turning the spotlight on breast cancer cells
20 March, 2014Scientists are using the latest in nano-flare technology to detect breast cancer cells early on.
Drug testing with synthetic livers
19 March, 2014Scientists from clinical intelligence company Empiriko have developed chemosynthetic liver technology which could enable the testing of drug candidates without using animals.
Biomarkers reveal short-term risk of death
05 March, 2014Researchers from Finland and Estonia have discovered novel biological markers that indicate an individual's risk of dying from any disease in the near future.
Successful phase 2 results in Huntington disease trial
24 February, 2014Prana Biotechnology has announced the results of its phase 2 clinical trial investigating the drug PBT2 as a treatment for Huntington disease.
€85 million to fight Gram-negative pathogens
13 February, 2014Over 30 European universities, research institutes and companies are joining forces in a six-year, €85 million program to develop novel antibiotics against Gram-negative pathogens.
What killed Knut, Berlin Zoo's polar bear?
07 February, 2014After one of the most intensive investigations in veterinary history for a single animal, what caused the death of Berlin Zoological Garden's polar bear, Knut, has been revealed.
Developing single-dose vaccines for cattle
06 February, 2014Researchers at The University of Queensland (UQ) are working on a single-dose (shelf-stable) vaccine that could be used to prevent common cattle diseases and reduce vaccination costs.
Identifying staph with a beacon, not a biopsy
04 February, 2014Researchers at the University of Iowa (UI) have created a probe that can detect a common strain of staph bacteria (Staphylococcus aureus) in the body. Their method has been published in the journal Nature Medicine.
